2002 (8 POSTS)

Lea IA, Widgren EE, O’Rand MG. 2002. Analysis of recombinant mouse zona pellucida protein 2 (ZP2) constructs for immunocontraception. Vaccine 20(11–12):1515–1523.

View Abstract

Gentry R, Teeguarden J, Sarangapani R, Covington T, Lawrence G, McDonald T, Shipp A, Clewell H. Evaluation of the potential impact of age- and gender-specific pharmacokinetic differences in tissue dosimetry. Poster presented at the Society of Toxicology Annual Meeting, Nashville, TN, March 2002.

2001 (12 POSTS)

Covington TR, Teeguarden J, Sarangapani R, Gentry PR, Clewell HJ. Evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry. Presentation at the Annual Society for Risk Analysis Conference, Seattle, WA, December 2001.

Clewell HJ, Gentry PR, Gearhart JM, Covington TR, Banton MI, Andersen ME. 2001. Development of a physiologically based pharmacokinetic model of isopropanol and its metabolite acetone. Toxicol Sci 63:160–172.

View Abstract

McMillan DA, Walden GL, Buchanan W. Peroxide degradation kinetics during use of Crest Whitestrips. J Dent Res 80(173), 2001.

McMillan DA, Gibb RD, Gerlach RW. Impact of increasing hydrogen peroxide concentration on bleaching strip efficacy and tolerability. J Dent Res 80:173, 2001.

O’Brien DP, Johnson GC, Liu L, Guo LT, Engvall E, Powell HE, Shelton GD. 2001. Laminin a 2 (merosin)-deficient muscular dystrophy and demyelinating neuropathy in two cats. J Neurol Sci 189:37–43.

View Abstract

Lau C, Mole ML, Copeland FM, Rogers JM, Kavlock RJ, Shuey DL, Cameron AM, Ellis DH, Logsdon TR, Merriman J, Setzer RW. 2001. Toward a biologically-based dose-response model for the developmental toxicity of 5-fluorouracil in the rat: Acquisition of experimental data. Toxicol Sci 59:37–48.

View Abstract

Setzer RW, Lau C, Mole ML, Copeland FM, Rogers JM, Kavlock RJ. 2001. Toward a biologically-based dose-response model for the developmental toxicity of 5-fluorouracil in the rat: A mathematical construct. Toxicol Sci 59:49–58.

View Abstract

Huang Y-S, Held G, Andrews JE, Rogers JM. 2001. 14C-Methanol incorporation into DNA and specific proteins of organogenesis-stage mouse embryos in vitro. Reprod Toxicol 15:429–435.

View Abstract

Shelton GD, Liu L, Guo LT, Smith GK, Christiansen JS, Thomas WB, et al. 2001. Muscular dystrophy in female dogs. J Vet Intern Med 15(3):240–244.

View Abstract

Lea IA, Sivashanmugam P, O’Rand MG. 2001. Zonadhesin: Characterization, localization, and zona pellucida binding. Biol Reprod 65(6):1691–700.

View Abstract

2000 (10 POSTS)

Shipp AM, Gentry PR, Lawrence G, Van Landingham C, Covington T, Clewell HJ, Gribben K, Crump K. 2000. Determination of a site-specific reference dose for methylmercury for fish-eating populations. Toxicol Ind Health 16(9-10):335–438.

View Abstract

Andersen ME, Sarangapani R, Gentry PR, Clewell HJ, Covington TR, Frederick CB. 2000. Application of a hybrid CFD-PBPK nasal dosimetry model in an inhalation risk assessment: An example with acrylic acid. Toxicol Sci 57:312–325.

View Abstract

Sagel PA, Odioso LL, McMillan DA, Gerlach RW. 2000. Vital tooth whitening with a novel hydrogen peroxide strip system: Design, kinetics, and clinical response. Comp Cont Educ Dent 21(Suppl. 29):10–15.

View Abstract

Jankowski-Hennig MA, Clegg MS, Daston GP, Rogers JM, Keen CL. 2000. Zinc-deficient rat embryos have increased caspase 3-like activity and apoptosis. Biochem Biophys Res Commun 271:250–256.

View Abstract

Lau C, Anderson ME, Crawford-Brown DJ, Kavlock RJ, Kimmel CA, Knudsen TB, Muneoka K, Rogers JM, Setzer RW, Smith G, Tyl R. 2000. Evaluation of biologically based dose-response modeling for developmental toxicity: A workshop report. Regul Toxicol Pharmacol 31:190–199.

View Abstract

O’Brien DP, Johnson GC, Liu L, Engvall E, Shelton GD. 2000. Laminin a 2 deficient muscular dystrophy in two cats. Research abstract program of 18th annual ACVIM Forum, Seattle, WA, May 2000. J Vet Intern Med 14(3):386.

View Abstract